Cancer Treatment Device Maker Beats Antitrust Claims

Law360, Houston (April 26, 2013, 9:13 PM ET) -- A Texas federal judge on Thursday rejected antitrust claims asserted by a medical device maker against unit of Elekta AB, ruling that the lawsuit did not sufficiently establish that the company monopolized the market for a radiation therapy component used to treat cancer.

U.S. District Judge Harry Lee Hudspeth ruled that Oncology Tech Inc. could not pursue claims under the Texas Antitrust Act or the Sherman Antitrust Act against Impac Medical Systems Inc., because analogues to Oncology Tech’s devices are readily available in the allegedly restricted...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers


Case Information

Case Title

Oncology Tech, LLC v. Elekta AB et al

Case Number



Texas Western

Nature of Suit

Contract: Other


Harry Lee Hudspeth

Date Filed

April 9, 2012


Law Firms Mentioned

Companies Mentioned